Skip to content


Superbugs

10/17/05 by Jonathan Kolber

It’s a shocking fact: 90,000 people die in U.S. hospitals each year from infections received inside the hospital. They come to be healed, but instead are killed.

This problem is so prevalent that doctors even have a name for it: iatrogenic disease.

According to the American Iatrogenic Association (yes, it’s that bad), a recent presidential task force called this a “national problem of epidemic proportions.” The estimated costs associated with this are $29 billion annually.

The Centers for Disease Control and Prevention estimates that 2 million people annually acquire infections while hospitalized – the 90,000 who die just happen to be the unluckiest of the bunch.

Let’s not be too quick to blame the doctors or hospitals for this. In most cases, they’re doing their best given what’s been available. Pathogens such as bacteria and viruses are surprisingly difficult to control.

Medical researchers are increasingly concerned about the emergence of “superbugs” resistant to commonly used antibiotics. These are significant contributors to those hospital deaths.

The fundamental problem is sterility. Despite all of the precautions taken in hospital environments, the reality is that trillions of disease organisms are introduced into a typical hospital every day. Infected people sneeze and cough, spraying organisms into the air. Outside air carries in whatever happens to be lurking in the vicinity.

It gets even worse when surgical procedures are involved. Normally, your skin provides a barrier against infection. That’s one of its primary functions, and it works in concert with your immune system to identify, isolate and destroy most pathogens before they can get a foothold.

Unfortunately, surgical procedures by their very nature open up the body’s inner tissues and organs to the outside environment. It’s unavoidable. The only way to prevent this would be to use “clean rooms” that go far beyond what’s affordable outside NASA and the computer chip industry.

What’s to be done?

Fortunately, one tiny company has the answer to safer surgical procedures – and it appears the FDA is about to grant it a whopping monopoly. This company has impressive management, healthy cash reserves, a wide array of issued patents and the perfect solution to sterilizing donated transplant tissue.

Author Image for Daily Reckoning Contributor

Daily Reckoning Contributor

The Daily Reckoning occasionally features commentary from financial analysts, experts, gold bugs, economists and an array of contributors from various fields and occupations. Their diverse insights and contrarian investing ideas are hand selected by your Daily Reckoning editors.

 

The Daily Reckoning is your premier source for making sense of the news Washington and Wall Street generate. Each business day, The Daily Reckoning calls on its stable of world-class writers and thinkers to show you how to get ahead.

Start your 100% FREE subscription to The Daily Reckoning today and you’ll get a free research report, “How to Survive the Fall of Social Security.” Simply enter your email address below to get your free report and join over 495,000 worldwide Daily Reckoning subscribers!

We Respect Your Privacy and We will
Never Share or Sell Your Email Address

Other Daily Reckoning Articles:


0 Responses

Some HTML is OK

(never shared)

or, reply to this post via trackback. Our Comment Policy.